Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
By G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, L. Vonghia, A. Mirijello, L. Abenavoli, C. d’Angelo, F. Caputo, A. Zambon and 2 more. The Lancet, 2007
634 citations recorded by the source corpus.
Subfields: Hepatology, Neurology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/ea91937e7a1fc96775abf5ebd90264612e65a5c8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pathology and Forensic Medicine
Citations in the corpus
- Alcoholism: a systems approach from molecular physiology to addictive behavior. (2009, neutral): “No hepatic side effects were recorded (3).”
- Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases (2020, positive): “(71,78) Notably, patients with hepatic encephalopathy were excluded from this trial, as baclofen may impair mentation, a side effect that may be exacerbated in more advanced liver disease.”